Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab

NCT05363631 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Clear Cell Renal Cell Carcinoma
Clear Cell Renal Cell Carcinoma Metastatic

Interventions

DRUG: Selenomethionine (SLM)
DRUG: Axitinib
DRUG: Pembrolizumab

Sponsor

Mohammed Milhem

Collaborators

[object Object]